2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Pediatric Oncology
- Progress in Treating Pediatric Solid Tumors
- Late Effects of Cancer Treatment in Childhood
- Emerging Therapies for Childhood Leukemia
- Genetic Syndromes Predisposing to Pediatric Cancers
Pediatric oncology is a specialized branch of cancer research focused on diagnosing and treating cancers in children. Unlike adult cancers, pediatric cancers often have distinct biological characteristics, making their treatment and prognosis different. Researchers in this field aim to understand the genetic and molecular drivers of childhood cancers, such as leukemia, brain tumors, and neuroblastoma, to develop more effective, less toxic therapies. Advances in pediatric oncology have led to significant improvements in survival rates, but challenges remain in reducing long-term side effects from treatments. Ongoing studies emphasize precision medicine, genetic therapies, and novel drug development to provide better outcomes for young patients. Collaborative efforts between research institutes, healthcare providers, and families play a crucial role in advancing pediatric oncology and ensuring a brighter future for children battling cancer.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Thomas J Webster
Northeastern University, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : Nanomedicine in humans: 30 years of fighting diseases
Thomas J Webster, Northeastern University, United States
Title : Diagnosis and treatment of primary cardiac lymphoma in an immunocompetent 27-year-old man
Moataz Taha Mahmoud Abdelsalam, Madinah Cardiac Center, Saudi Arabia
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Personalized and Precision Medicine (PPM) through the view of biodesign-inspired translational research: An option for clinical oncologists, caregivers, and consumers to realize the potential of genomics-informed care to secure human biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation